Skip to main content

Table 2 Laboratory parameters on admission

From: Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study

 

Total (n = 49)

RASi(+) (n = 37)

RAS(-) (n = 12)

p value

Hematocrit (%)

37.9 ± 7.8

37.8 ± 8.3

37.6 ± 5.9

0.930

Platelet count (× 104/mm3)

20.4 ± 7.9

20.0 ± 8.4

21.8 ± 6.3

0.494

LDH (U/L)

447 ± 354

493 ± 391

307 ± 132

0.114

Total protein (g/dL)

6.7 ± 0.9

6.7 ± 0.2

6.5 ± 0.3

0.484

Serum potassium (mEq/L)

3.8 ± 0.9

3.7 ± 0.9

4.1 ± 0.8

0.176

LDL-cholesterol (mg/dL)

121 ± 29

120 ± 26

123 ± 40

0.814

HDL-cholesterol (mg/dL)

45 ± 12

46 ± 12

42 ± 13

0.393

Hemoglobin A1c (%)

5.4 ± 1.0

5.4 ± 1.1

5.6 ± 0.6

0.489

eGFR (mL/min/1.73m2)

33.2 ± 23.3

35.1 ± 22.6

27.3 ± 25.5

0.319

Urine protein (g/gCr)

3.11 ± 3.29

2.61 ± 2.76

3.23 ± 2.61

0.148

Plasma renin activity (ng/mL/hr)

26 ± 38

30 ± 43

12 ± 12

0.134

Plasma aldosterone (pg/mL)

290 ± 243

329 ± 265

173 ± 100

0.055

  1. LDH lactate dehydrogenase